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S U M M A R Y
Objectives: To examine the appropriateness of antibiotics prescribed for acute infection based on the
Malaysian national antibiotic guidelines and the deﬁned daily dose (DDD) system of the World Health
Organization (WHO). This study also aimed to describe the factors inﬂuencing the drug use pattern and
to investigate the procurement patterns of antibiotics in the primary healthcare setting.
Methods: A retrospective cohort follow-up study of randomly selected patients from all patients who
received any antibiotic between January and December 2013 was conducted at three primary healthcare
clinics in Selangor State of Malaysia. For each patient, the following information was recorded: name of
the antibiotic, frequency and dose, and Anatomical Therapeutic Chemical (ATC) group. The deﬁned daily
dose per 1000 inhabitants per day was calculated for each antibiotic. The national antibiotic guidelines
were used to assess the appropriateness of each antibiotic prescription.
Results: A total of 735 patients were included in the study. The ﬁve most used antibiotics were
amoxicillin (1.36 g, 35.2%), cloxacillin (0.68 g, 26.3%), erythromycin (0.32 g, 22.3%), bacampicillin (0.13 g,
7.2%), and cephalexin (0.11 g, 6.9%). Respiratory tract infections were the most commonly treated
infections, and the doctors’ preferred antibiotic for the treatment of these infections was amoxicillin.
More than 18% of all amoxicillin prescriptions were deemed inappropriate according to the national
antibiotic guidelines. In terms of procurement costs, USD 88 885 was spent in 2011, USD 219 402 in
2012, and USD 233 034 in 2013 at the three primary healthcare clinics, an average of USD 180 440 per
year for the three clinics.
Conclusions: This study reports the antibiotic usage at three primary healthcare clinics in Klang Province.
The most prescribed antibiotic was amoxicillin in capsules (250 mg), which was mainly prescribed for
respiratory infections. Although the national antibiotic guidelines state that amoxicillin is a preferred
drug for acute bacterial rhinosinusitis, this drug is also being prescribed for other disease conditions,
such as acute pharyngitis and acute tonsillitis. This result shows that current practice is not following the
current antibiotic guidelines, which state that phenoxypenicillin should be the preferred drug.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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In 2011, about 10.1% of annual drug expenditure for primary
care clinics was used for antibiotics. Approximately 164.97 million
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).spent for the purchase of antibiotics for all Ministry of Health
hospitals and primary care clinics.1 In the primary care setting, oral
antimicrobial drugs feature consistently in the top therapeutic
classes of drugs in terms of frequency of use and cost. Thus, the
antibiotic usage pattern should be monitored to determine the
appropriateness of use and the cost burden of antibiotics in
primary care.
Inappropriate prescribing will eventually cause treatment
failure and poses a threat to patient safety, which may lead to
other issues, such as non-adherence and wastage of resources.2ociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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antibiotics. These factors may include the limited knowledge and
experience of the medical practitioner, personal preference, and
parental or patient pressure.3,4 Physicians and patients both play
an important role in monitoring drug use patterns. Prescription
decisions and patterns are inﬂuenced by the patient’s expectations
and the doctor’s perception of the patient’s expectations.5
Although the guidelines provided by the Malaysian Ministry of
Health can be considered the basis for the rational use of antibiotics
in the healthcare setting, it is difﬁcult to ensure that these
guidelines are diligently followed. One method to ensure correct
prescribing and use is through the undertaking of a drug utilization
study (DUS). The DUS evaluates the marketing, distribution,
prescription, and use of drugs in society, with speciﬁc emphasis
on the resulting medical, social, and economic consequences.
Healthcare providers should focus on certain components of drug
use with regard to DUS criteria; these components include the use,
selection, dosage, interactions, and preparation. The DUS plays a key
role in understanding, interpreting, evaluating, and improving the
prescription, administration, and use of medications. Policymakers
and procurement management personnel ﬁnd DUS valuable
because the results may be used to promote the efﬁcient use of
scarce healthcare resources.6 In addition, DUS can be a tool to detect
abuse and inappropriate drug usage, which are possible in certain
healthcare settings. The DUS can be performed as a prospective,
current, or retrospective study. The retrospective DUS involves a
review of drug therapy after the patient has completed the course of
therapy. This review poses less risk of bias because the prescriber is
not aware of the data collection.7
The prescription of antibiotics is mainly indicated for the
empirical therapy of upper respiratory tract infections (URTIs),
urinary tract infection (UTIs), and mild community-acquired
pneumonia.1,8 A surveillance study conducted among Malaysian
Ministry of Health hospitals found that antibiotics are often used
for therapeutic uses and are commonly given to patients with
lower respiratory tract infections.4 Another study showed that
antibiotics are more often prescribed for patients with URTIs than
for those without an URTI.9 Nevertheless, the national antimicro-
bial resistance surveillance data in 2007 showed high resistance of
Gram-negative bacteria, such as Klebsiella spp (99%), Enterobacter
spp (93%), Escherichia coli (69%), Proteus spp (48%), and Haemophilus
inﬂuenzae (20%), to ampicillin. Hence, the use of these antibiotics as
empirical therapy in the primary healthcare setting should be
reviewed and changed.10
Information on the utilization and appropriateness of antibiotic
use among adults in the primary healthcare setting is important,
especially when the antibiotics are prescribed for acute diseases.
The effectiveness of the antibiotics and occurrence of adverse drug
reactions might be related to usage patterns. Thus, a DUS on
antibiotic usage should be performed to ensure the implementa-
tion of the current drug policies and drug formulary at the health
clinic level. Additionally, there is a paucity of pertinent data from
cross-sectional and retrospective studies on the comparative
prescribing of medical specialist versus medical doctor.
The aim of the present study was to examine the appropriate-
ness of antibiotics prescribed for acute infections based on the
Malaysian national antibiotic guidelines of 2014 and the deﬁned
daily dose (DDD) system of the World Health Organization (WHO).
Furthermore, this study also aimed to describe the factors
inﬂuencing the drug use pattern and to investigate the procure-
ment patterns of antibiotics in the primary care setting.
2. Materials and methods
This was a retrospective study examining the utilization of
selected antibiotics in three government health clinics. The healthclinics selected are situated in Klang (Anika), Pandamaran, and
Bukit Kuda, which are all within Klang Province. Klang Province has
a total of 11 health clinics that offer primary health maintenance
services. The clinics at Pandamaran, Anika, and Bukit Kuda are
under the management of Klang Province Health Department.
Klang Province had a population of 744 062 in 2010. These three
large-scale health clinics are located in the centre of the Province of
Klang and have the highest population densities. They provide
general outpatient care, maternal and child care, dental care, and
rehabilitation care. In addition, they also provide laboratory and
radiological services. Patients attending these clinics are seen by
non-specialist medical doctors or primary care specialists, who are
known locally as family medicine specialists.
2.1. Data collection
Information was collected from the electronic clinic manage-
ment system dispensing records and proﬁle databases. For inclusion
in the study, the patient had to be aged between 18 and 60 years and
to have been prescribed oral antibiotics. Patients given topical
antibiotics, dental treatment, or prophylaxis were excluded from
this study. All records of patients attending the three clinics during
the period January to December 2013, who fulﬁlled the necessary
criteria, were screened. Out of these records, 245 records from each
clinic were chosen at random based on numbering in an
alphabetical list. Data gathered from all dispensing records of
encoded antibiotics were collected. The prescribed medicine,
frequency, and dose were recorded for each patient to obtain the
DDD per 1000 inhabitants per day. The national antibiotic
guidelines 2014 were used to evaluate the quality of prescription.
Comparisons of the DDD between drugs and clinics were assessed
against the prescriber and patient characteristics.
2.2. Outcome parameter
The Anatomical Therapeutic Chemical (ATC) classiﬁcation
system is issued by the WHO as a tool for presenting drug
utilization statistics in international comparisons. In this classiﬁca-
tion, each active ingredient of a drug is given a distinct code.
Furthermore, the DDD is deﬁned as ‘‘the average maintenance dose
of the drug when used on its major indication in adults’’.11 The DDD
can be related to drugs with the ATC classiﬁcation (Table 1). The
DDD does not reﬂect the prescribed daily dose or recommended
dose for the treatment of each patient. However, the DDD is the
average maintenance dose taken by adult patients for certain
indications. The DDD is also a unit of measurement that can be used
as a tool for presenting drug utilization statistics for consideration
by pharmacy and therapeutic committee members in drug
utilization reviews and drug regimen review activities.12 The
DDD can be presented in many ways; for example, the DDD can
be expressed as the DDD per 1000 inhabitants per day when
describing chronic disease drug use, or as the DDD per 100 bed-days
if inpatient drug use is described.13 In the present study, the DDD per
1000 patients per day (DID) was used. The DDD result was compared
with the current WHO classiﬁcation of ATC/DDD for the DDD
analysis.12 The antibiotics used in this study are listed in Table 1.
In this study, the data were recorded as the DDD per
1000 inhabitants per day. The quantity of drug use was calculated
as follows: DDD/1000 inhabitants/day = T  1000/(DDD  P  365),
where T is an estimate of the total quantity of the drug (mg) utilized
in the year under consideration, DDD is the DDD assigned for the
drug according to the ATC/DDD system, P is the population of health
clinics studied, and 365 refers to the 365 days in a year.
The DDD was compared to the treatment agreed in the national
antibiotic guidelines to assess the prescribing quality and
appropriateness.
Table 1
List of deﬁned daily doses and ATC codes for selected antibiotics
ATC code Drug class and agent DDD from WHO (g)
J01C A04 Amoxicillin 1
J01C R02 Amoxicillin and enzyme inhibitor 1
J01C F02 Cloxacillin 2
J01D B01 Cephalexin 2
J01D D04 Ceftriaxone 2
J01C E02 Phenoxymethylpenicillin 2
J01C E08 Benzathine benzylpenicillin 3.6
J01C A06 Bacampicillin 1.2
J01F A01 Erythromycin ethylsuccinate 2
J01D C02 Cefuroxime 0.5
J01E E01 Sulfamethoxazole and trimethoprim 1.92
J01A A07 Tetracycline 1
J01A A02 Doxycycline 0.1
ATC, Anatomical Therapeutic Chemical; DDD, deﬁned daily dose; WHO, World
Health Organization.
Table 2
Socio-demographic characteristics of the patients
Characteristics Number (%)
Age, years
18–30 304 (41.4)
31–45 224 (30.5)
46–60 207 (28.1)
Sex
Male 291 (39.6)
Female 444 (60.4)
Ethnicity
Malay 296 (40.3)
Indian 282 (38.4)
Chinese 112 (15.3)
Other 45 (6.1)
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Data were analyzed using IBM SPSS Statistics version 22.0 (IBM
Corp., Armonk, NY, USA) and Microsoft Excel version 2010. Data
from the patient’s prescription record and demographic proﬁle
were assessed using descriptive statistics, such as the mean and
standard deviation (SD).
2.4. Ethical considerations
This study was approved by the Ethics Committee of Universiti
Teknologi MARA and the Clinical Research Centre, Ministry of
Health Malaysia. All authors ensured that all data, such as the
patient proﬁles and medical records retrieved from the health
information system (Teleprimary Care), were strictly used for
research purposes; conﬁdentiality was maintained.
3. Results
A total of 3902 patients attended the three health clinics
between January and December 2013. Among the medications
dispensed, 17 different antibiotics were used a total of 4460 times.
A total of 3879 patients were eligible for further investigation.
From the database, 404 (10.4%) patients were prescribed more
than one antibiotic within the year 2013, and a total of 167 patients
(4.3%) were dispensed different classes of antibiotics throughout
the year. All patient IDs were gathered in ascending order and
selected at random. The procedure resulted in the selection of data
from a total of 735 patients, which was about 18.9% of the total
population.
3.1. Socio-demographic characteristics
The records of a total of 735 patients were analyzed. There were
signiﬁcantly more females than males (60.4% vs. 39.6%). The mean
age (SD) of the patients was 36.11 (12.66) years. In terms of
ethnicity, approximately 40.3% were Malay, 38.4% Indian, 15.3%
Chinese, and 6% other ethnicities (Table 2).
3.2. DDD of antibiotics
The doses consumed per day were estimated to obtain the DDD
of each antibiotic in 2013 (Figure 1). The total antibiotics used for
the three clinics was 2.675 DID. The ﬁve most utilized antibiotics
were amoxicillin (1.36 DID), cloxacillin (0.68 DID), erythromycin
(0.32 DID), cephalexin (0.11 DID), and bacampicillin (0.13 DID).
Amoxicillin was found to be the most utilized antibiotic in the
population, and was used about two-fold more than cloxacillin.The least utilized antibiotics were cefuroxime, trimethoprim–
sulfamethoxazole, doxycycline, and amoxicillin–clavulanic acid.
The patients aged 18–30 years had the highest DDD for antibiotics
(Figure 2).
In terms of the site of infection, most were respiratory
infections. Amoxicillin had the highest DDD in the three health
clinics for respiratory infection, followed by erythromycin. For
respiratory infections, the DDD was also higher for amoxicillin;
therefore, amoxicillin was the most used drug to treat these
conditions. About 54.2% of the patients were prescribed amoxicil-
lin capsules (250 mg); this accounted for 65.4% of patients
diagnosed with an URTI. According to the national antibiotic
guidelines, amoxicillin is not a suitable drug for the treatment of
URTIs, except for acute bacterial rhinosinusitis. In the clinics,
amoxicillin was prescribed for acute tonsillitis (6.5%, n = 14) and
acute pharyngitis (11.9%, n = 26). However, the appropriate drug
for acute tonsillitis and acute pharyngitis is phenoxymethylpeni-
cillin.14
The results showed that all age groups received cephalexin for
UTIs in accordance with the national antibiotic guidelines.
Amoxicillin usage in patients with skin and soft tissue infections
in the age groups 31–45 years and 46–60 years was in accordance
with the national antibiotic guidelines. About 60% of prescriptions
for patients aged 18–30 years followed the indications in the
national antibiotic guidelines. However, no signiﬁcant difference
was observed between age groups for the rate of concordance with
the WHO DDD and national antibiotic guidelines.
3.3. Factors inﬂuencing the antibiotic pattern
3.3.1. Patient characteristics
Patients were classiﬁed into three groups according to their
age; 18–30, 31–45, and 46–60 years. No signiﬁcant differences
were found in the prescribing pattern for most of the antibiotics.
Nevertheless, some differences were observed in speciﬁc age
groups. For instance, bacampicillin tablets (400 mg) were fre-
quently prescribed in the 18–30 years group. In addition, male
patients aged 31–45 years received 1.5 dose of cloxacillin.
3.3.2. Physician characteristics
Physician characteristics are an important determinant in
antibiotic utilization. Some physicians fear that disease outcomes
may be poor without antibiotic treatment. Therefore, they tend to
prescribe inappropriately to obtain the preferred results. The peer
norms and local medical culture are important inﬂuences on
prescribing behaviour.15
In this study, primary care specialists prescribed only 1.4% of
antibiotics. The use of the specialist-prescribed item cefuroxime by
primary care specialists was only 10% (specialist-prescribed items
are known locally as medication list A); the other antibiotics
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Figure 1. Deﬁned daily dose (DDD) of antibiotics for all three selected clinics.
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medication list B) (Table 3).
3.4. Procurement data
From 2011 to 2013, an upward trend in overall procurement of
antibiotics was seen. However, some antibiotics, such as cepha-
lexin monohydrate capsules (250 mg), showed a decreasing trendFigure 2. Deﬁned daily dose (DDD) of the most ﬁve usefrom 2012 to 2013 (Table 4). There was a 2.6-fold increase in total
cost of antibiotics procured from the year 2011 to 2013 (Table 4).
The highest expenditure for all 3 years was for amoxicillin capsules
(250 mg). The top ﬁve antibiotics purchased were amoxicillin
capsules (250 mg, 36%), erythromycin ethylsuccinate tablets
(400 mg, 12.9%), cloxacillin sodium capsules (250 mg, 8.9%),
cephalexin monohydrate capsules (250 mg, 6.8%), and erythromy-
cin ethylsuccinate 200 mg/5 ml suspension (6.7%). Amoxicillind antibiotics for each clinic according to age range.
Table 3
Prescription frequencies by type of prescriber according to the antibiotics
Antibiotic type Specialist (n = 10) Non-specialist (n = 725)
n % n %
Amoxicillin 250 mg capsule 1 10.00 255 35.2
Bacampicillin 400 mg tablet 0 0 52 7.2
Cefuroxime axetil 250 mg tablet 1 10.0 1 0.1
Cephalexin monohydrate 250 mg capsule 1 10.0 50 6.9
Cloxacillin sodium 250 mg capsule 2 20.0 191 26.3
Erythromycin ethylsuccinate 400 mg tablet 1 10.0 162 22.3
Sulfamethoxazole 400 mg + trimethoprim 80 mg tablet 3 30.0 7 1.0
Doxycycline 100 mg capsule 0 0 5 0.7
Amoxicillin + clavulanic acid 625 mg tablet 1 10.0 0 0.0
Cloxacillin sodium 125 mg/5 ml suspension 0 0 1 0.1
Cefuroxime axetil 125 mg tablet 0 0 1 0.1
Table 4
Cost of antibiotics purchased (in Malaysian ringgit (MYR); 1 MYR = USD 0.24)
Antibiotics 2011 2012 2013
Amoxicillin 250 mg capsule 103 898 370 443 304 854
Cloxacillin sodium 250 mg capsule 23 932 155 022 168 292
Cefuroxime 125 mg tablet NA NA 132 560
Erythromycin ethylsuccinate 400 mg tablet 117 898 86 196 74 360
Erythromycin ethylsuccinate 200 mg/5 ml suspension 15 392 71 113 58 199
Bacampicillin hydrochloride 400 mg tablet 16 590 23 431 47 268
Cloxacillin 125 mg/5 ml suspension 5728 14 637 35 567
Amoxicillin and clavulanic acid 625 mg tablet 7437 27 326 33 895
Cephalexin monohydrate 250 mg capsule 30 723 82 066 33 735
Amoxicillin trihydrate 125 mg/5 ml syrup 16 023 9435 11 236
Cefuroxime axetil 250 mg tablet 2396 7605 10 904
Phenoxymethylpenicillin 125 mg tablet 1220 13 567 8778
Cephalexin 125 mg/5 ml syrup 6950 5089 3680
Doxycycline hyclate 100 mg capsule 1811 4243 3553
Sulfamethoxazole 400 mg and trimethoprim 80 mg tablet 1519 4976 2744
Benzathine penicillin 2.4 MIU injection 1159 1895 1707
Ceftriaxone 0.25 g injection 555 561 804
Sulfamethoxazole 200 mg + trimethoprim 40 mg/5 ml syrup 1656 - -
Tetracycline HCl 250 mg capsule 656 - -
Total 355 542 877 608 932 136
NA, Not Available.
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per pill was slightly more expensive (MYR 0.46). Most of the
antibiotic prices had increased in 2012 (Table 4). This increase
contributed indirectly to the increase in total procurement costs
from 2011 to 2012.
4. Discussion
Procurement data are important in DUS. These data are used to
portray whether the antibiotic usage is concurrent with the
antibiotics purchased. From 2011 to 2012, the procurement trend
for antibiotics showed an ascending pattern. A factor that
contributed to the ascending pattern in antibiotics was the
incremental increase in price per pill in 2012. From 2011 to
2012, price differences were observed for amoxicillin capsules
(250 mg, MYR 0.32/tablet), cloxacillin sodium capsules (250 mg,
MYR 0.23/tablet), and phenoxymethylpenicillin tablets (125 mg,
0.33/tablet). A decreasing purchasing trend was observed in 2013,
speciﬁcally for amoxicillin capsules (250 mg, 17.7%) and cepha-
lexin monohydrate capsules (250 mg, 58.9%). This change might
have been caused by an increasing stock holding in 2013 for both
antibiotics (amoxicillin capsules (250 mg) = 31.8% and cephalexin
monohydrate capsules (250 mg) = 3.6%). Furthermore, antibiotics
with a constantly increasing purchasing trend each year, such as
cloxacillin sodium capsules (250 mg), amoxicillin and clavulanic
acid tablets (625 mg), and bacampicillin hydrochloride 400 mg
tablets, are still available. Analysis of the results of the utilizationdata showed that in 2013 amoxicillin capsules (250 mg) were the
most prescribed antibiotic, followed by cloxacillin capsules
(250 mg) and erythromycin tablets (400 mg). Therefore, the
purchasing criteria were followed, which were concurrent with
drug usage.
In 2013, cefuroxime 125 mg tablets were procured for the ﬁrst
time. These tablets cost 132 560 MYR (equivalent to USD 35 000),
which had a great impact on the total antibiotic procurement.
However, the usage of cefuroxime 125 mg tablets was low (MYR
569). Consequently, the antibiotic was overstocked in 2013
(31.8%). The antibiotics were overestimated because they were a
ﬁrst-time purchase, and no prediction on utilization could be
estimated based on previous data. Also, the antibiotic was listed as
a specialist-prescribed item, and only primary care specialists are
authorized to prescribe these, hence the antibiotic was a slow-
moving item. The 2.6-fold increase in the total cost of antibiotics
over the years 2011–2013 was largely due to the high procurement
of amoxicillin capsules (250 mg).
Of note, the most utilized antibiotics were amoxicillin
(1.36 DID), cloxacillin (0.68 DID), and erythromycin (0.32 DID).
The results of the present study are comparable to those of a study
conducted in India that reported an overall medicine consumption
of 1.53 DID, with about 98.3% contributed by antibiotics and about
50% serving as empirical antimicrobial therapy. However, the most
widely used antibiotics were artesunate (13%), ceftriaxone (11%),
and metronidazole (10.5%) because of community infections of
malaria and typhoid.16
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Medicine Use Survey, and the report was published as the
Malaysian Statistics on Medicines (MSOM).17 The MSOM collected
data on drugs utilized in the private and government sectors,
including hospitals, primary healthcare, and health institutions.
Unfortunately, the data were combined, and individual data were
not stated. Thus, no direct comparisons can be made with previous
data for primary healthcare clinics.17 The MSOM reported that
amoxicillin (DDD 0.73 g), cephalexin (DDD 0.058 g), and erythro-
mycin (DDD 0.53 g) were the three most utilized antibiotics. These
results are in agreement with the current study regarding the top
three antibiotics used, but the doses differ: amoxicillin (DDD
1.36 g), cephalexin (DDD 0.11 g), and erythromycin (DDD 0.32 g).
These results appear to be in agreement with those from other
Asian countries, such as China, where cephalosporins, penicillin,
and macrolides are the most utilized antibiotics.18
The difference between the DDD in primary healthcare clinics
and government hospitals was high in the MSOM, probably
because the choice of antibiotic classes is broad in government
hospitals. For example, amoxicillin is classiﬁed as penicillin with
extended spectrum (J01C A). By contrast, the choices are limited in
primary healthcare clinics, and only amoxicillin and bacampicillin
can be prescribed by non-specialist medical doctors. The limited
choice will indirectly increase amoxicillin usage when compared
with other referral government hospitals with specialist medical
doctors in the MSOM. The MSOM cover government hospitals and
primary healthcare clinics. Thus, the drug choices are broad, and
they cover all classes of drugs registered in Malaysia.
According to the MSOM, amoxicillin is among the most widely
used drugs in both government and private sectors. It is probably
used for URTIs, UTIs, and mild community-acquired pneumonia.
The results of the present study showed that amoxicillin was
inappropriately prescribed for some URTI cases (about 18.4% of the
URTI cases), such as tonsillitis and pharyngitis. This ﬁnding is
comparable to that of a study conducted by Teng et al., which
demonstrated an excessive antibiotic prescription for URTI, and
the antibiotic choices for both URTI and UTI were not consistent
with the guidelines.4 Similar results were reported from
Zimbabwe, where about 12.3% of the prescribed antibiotics were
evaluated as inappropriate. A study from China documented that
only 60.6% of the prescribed antibiotics for outpatients were
considered inappropriate for outpatient clinics.18
In the present study, only cephalexin was prescribed in
accordance with the national antibiotic guidelines (100%) for
UTI. Most of the antibiotics did not comply with the DDD, perhaps
because of the prescribing trends, and the dose was based on the
diagnosis. This study revealed no signiﬁcant inﬂuence of patient
characteristics on the antibiotic prescribed. These results are in
accordance with those of a previous study conducted in Seremban
Province, which found that antibiotic prescription is not inﬂuenced
by age, sex, race, comorbidity, or duration of symptoms data.19
Prescriber behaviour is one of the determinants of antibiotic
utilization. Prescribers are often concerned about the outcomes of
their prescriptions being poor or delayed. This concern may lead to
the over-prescription of antibiotics and a lack of compliance with
the guidelines. Studies from other countries, including those in
Europe, have reported the same problem; for example, general
practitioners in Ireland have been shown not to adhere to the
antibiotic prescription guidelines.20
Prescription authority is also one of the factors inﬂuencing the
prescribing pattern. For example, only primary care specialists
have the authority to prescribe restricted antibiotics (medication
list A). Newer antibiotics will also be restricted. This restriction
indirectly helps prevent the development of resistance because the
medical ofﬁcer has to obtain the approval of primary care
specialists before prescribing these antibiotics. From the observeddata, approximately 99% of antibiotics are prescribed by a junior
medical doctor. The present study showed that about 0.2% of junior
medical doctors prescribed restricted antibiotics. In such a
situation, the non-specialist medical doctor should obtain approval
by countersigning the prescription, or the primary care specialist
should be called before the prescription is fulﬁlled.
Patient behaviour also contributes to the utilization of
antibiotics; the patient may demand antibiotics without valid
reasons. In some instances, the prescriber feels the need to fulﬁl the
patient’s request for an antibiotic even if their illness has a viral
aetiology, because of the patient’s persistent requests.21 A lack of
knowledge and compliance with antibiotics are important
determinant factors in contributing to utilization. Patients have
little knowledge of the importance of compliance in consuming
antibiotics.22–24 Thus, they may cease therapy before the full
course has been taken in the case where symptoms have resolved.
Skipping therapy may indirectly lead to more frequent visits
because of the antibiotic resistance caused by unnecessary
increased antibiotic utilization.
Necessary measures should be taken to regulate antibiotic
prescription. Factors leading to a deviation from the prescriber’s
choice of antibiotics should be investigated. These issues should
be proposed at the drug committee meeting of each clinic.
Collaboration between the pharmacist and prescriber is impor-
tant to monitor the prescribing pattern of antibiotics. Pharma-
cists should be proactive and establish a good rapport with
prescribers so that compliance with the guidelines can be
instilled. Continuous education will ensure that prescribers are
up to date with all of the guidelines and procedures for the
selection and use of drugs.
An antibiotic audit should be routine practice to ensure quality
prescribing of antibiotics in primary care services. This measure
will help to optimize the appropriate utilization and gather
information on antibiotic susceptibility patterns, which is still
lacking for the primary care level. Hence, pharmacists must attain
knowledge on how to implement the DDD and initiate utilization
studies to present the ﬁndings at drug committee meetings. When
antibiotics are inappropriately used, the managerial level of the
Province Health Ofﬁce should be alerted to the situation so that
improvement measures can be initiated.
In conclusion, this study investigated the antibiotic usage
at three health clinics in Klang Province. The most frequently
prescribed antibiotic was amoxicillin in the form of 250 mg
capsules; this was mainly prescribed for respiratory infections.
Although the national antibiotic guidelines state that amoxicil-
lin is a preferred drug for acute bacterial rhinosinusitis,
this drug is also being prescribed for other disease conditions,
such as acute pharyngitis and acute tonsillitis. This result
shows that current practice is not following the antibiotic
guidelines, which state that phenoxypenicillin should be the
preferred drug.
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